Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pb-201 (2 trials)
vildagliptin (1 trial)
pb-119 (6 trials)
sitagliptin (januvia) (1 trial)
buspirone (buspar) (1 trial)
exenatide (byetta) (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 2 (Phase 2)
Trials (9 total)
Trial APIs (6 total)